Nitric oxide, nitric oxide synthase, and hypertensive vascular disease Rudi BusseIngrid Fleming OriginalPaper Pages: 88 - 95
Endothelin in cardiovascular control: The role of endothelin antagonists René R. WenzelPeter CzyborraThomas Philipp OriginalPaper Pages: 79 - 87
Endothelin and its antagonists in hypertension: Can we foresee the future? Pierre MoreauTon J. Rabelink OriginalPaper Pages: 69 - 78
Treating hypertension: How low is optimal and does aspirin help? R. Wayne Alexander OriginalPaper Pages: 59 - 61
Cardiac genes and gene databases for cardiovascular disease genetics Kiat T. TanAdam A. DempseyChoong-Chin Liew OriginalPaper Pages: 51 - 58
Gene-environment interactions in hypertension Zdenka PausovaJohanne TremblayPavel Hamet OriginalPaper Pages: 42 - 50
Angiotensinogen variants and human hypertension Xavier JeunemaitreAnne-Paule Gimenez-RoqueploPierre Corvol OriginalPaper Pages: 31 - 41
Use of animal models to search for candidate genes associated with essential hypertension Margit KnoblauchKlaus Lindpaintner OriginalPaper Pages: 25 - 30
Linkage mapping for hypertension susceptibility genes Norihiro KatoCècile Julier OriginalPaper Pages: 15 - 24
Review of “angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II” Nicholas J. Schork OriginalPaper Pages: 13 - 14
Current controversies in blood pressure in diabetic nephropathy Eberhar RitzMichael Schömig Invited Commentary Pages: 9 - 10
Pathogenesis of hypertension: Genetic and environmental factors vascular mechanisms Literature Alert Pages: 4 - 8
Pathogenesis of hypertension: Genetic and environmental factors vascular mechanisms Web Alert Pages: 1 - 3
